THERAPEUTICS OF X-LINKED HYPOPHOSPHATEMIC RICKETS

被引：11

作者：

LATTA, K ^{[1
]}

HISANO, S ^{[1
]}

CHAN, JCM ^{[1
]}

机构：

[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,CHILDRENS MED CTR,DEPT PEDIAT,DIV NEPHROL,RICHMOND,VA 23298

来源：

PEDIATRIC NEPHROLOGY | 1993年 / 7卷 / 06期

关键词：

X-LINKED HYPOPHOSPHATEMIC RICKETS; NEPHROCALCINOSIS; HYPERCALCIURIA; PREGNANCY;

D O I：

10.1007/BF01213343

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

X-Linked hypophosphatemia, the most common form of familial rickets, is conventionally treated with 1,25-dihydroxyvitamin D-3 (5-50 ng/kg per day) plus phosphate supplementation (70-100 mg/kg per day). However, nephrocalcinosis is noted in many children treated with this therapy. Whether to treat or not and whether such treatment should be continued into adulthood or in pregnancy are unsettled questions. This article reviews these controversies and provides current recommendations.

引用

页码：744 / 748

页数：5

共 36 条

[11]

Alon U., Chan J.C.M., The effects of hydrochlorothiazide and amiloride in renal hypophosphatemic rickets, Pediatrics, 75, pp. 754-763, (1985)

[12]

Alon U., Chan J.C.M., Effects of PTH and 1,25(OH)<sub>2</sub>D<sub>3</sub> on tubular handling of phosphate in hypophosphatemic rickets, J Clin Endocrinol Metabol, 58, pp. 671-675, (1984)

[13]

Tsuru N., Chan J.C.M., Chinchilli V.M., Renal hypophosphatemic rickets. Growth and mineral metabolism after treatment with 1,25-dihydroxyvitamin D and phosphate supplementation, Am J Dis Child, 141, pp. 108-110, (1987)

[14]

Stendijk J.K.R., Hauspier C., Pattern of growth and growth retardation of patients with hypophosphatemic vitamin D resistant rickets: a longitudinal study, European Journal of Pediatrics, 151, pp. 422-427, (1992)

[15]

Verge C.F., Lam A., Simpson J.M., Cowell C.T., Howard N.J., Silink M., Effects of therapy in X-linked hypophosphatemic rickets, N Engl J Med, 325, pp. 1843-1848, (1991)

[16]

Balsan S., Tieder M., Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: influence of treatment regimen and parental height, J Pediatr, 116, pp. 365-371, (1990)

[17]

Reusz G.S., Hoyer P.F., Lucas M., Krohn H.P., Ehrich J.H.H., Brodehl J., X-linked hypophosphatemia: treatment, height, gain and nephrocalcinosis, Arch Dis Child, 65, pp. 1125-1128, (1990)

[18]

Smith R., Newman R.J., Radda G.K., Stokes M., Young A., Hypophosphatemic osteomalacia and myopathy: studies with nuclear magnetic resonance spectroscopy, Clin Sci, 67, pp. 505-509, (1984)

[19]

Econs M.J., Saa G.P., Monger M., Drezner M.K., Feussner J.R., Frequent misdiagnosis of X-linked hypophosphatemic rickets, J Bone Miner Res, 7, (1992)

[20]

Clark C.D., Kainer G., Conway W.F., Chan J.C.M., Intramyocellular phosphate metabolism in X-linked hypophosphatemia, The Journal of Pediatrics, 116, pp. 288-292, (1990)

← 1 2 3 4 →